You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Antiplatelet drug acting via purinergic receptors, not largely impacted by CYP2C19 polymorphism is: and explain in detail?
Ref. KDT. Page. 629
Prasugrel is a prodrug , similar to Clopidogrel

Thienopyridine drug class
Irreversible antagonist of P2Y12 ADP receptors
Rapidly absorbed, completely activated & exerts more consistent platelet inhibition. No interaction with CYP2C19 polymorphism
Strong anti-platelet activity
Bleeding complications are more serious and frequent.
Contraindicated in patients with history of ischemic strokes and TIA’s